Sotrovimab May Help Prevent Long-COVID in High-Risk Patients: Study Dr. Shravani Dali7 April 2025 9:00 PM ISTResearchers from the UK and US have found in a new study that early treatment with the monoclonal antibody sotrovimab not only helps high-risk...
USFDA revokes authorization of COVID antibody drugs of GSK, Lilly and 2 others Ruchika Sharma24 Dec 2024 12:30 PM ISTThe US Food and Drug Administration (USFDA) has revoked the emergency use authorisation for four Covid-19 antibody-based drugs from pharma...
Monoclonal antibody treatment for COVID-19 stands safe in pregnancy: Study Dr. Kamal Kant Kohli28 Nov 2022 9:45 AM ISTPennsylvania : A single-center study published in Annals of Internal Medicine found that monoclonal antibody therapy for COVID-19 was safe to use...
Medical Bulletin 19/November/2022 Dr. Nandita Mohan19 Nov 2022 2:00 PM ISTHere are the top medical news for the day:Ultrasound-guided surgery is quicker, less painful and more effective for treating early form of breast...
Studies provide latest 'real world' evidence on effectiveness of covid-19 treatments Dr. Nandita Mohan19 Nov 2022 10:30 AM ISTThe debate around the effectiveness of COVID-19 treatments has been ongoing and often appears never-endingTwo studies published by The BMJ today...
Sotrovimab effective treatment option for COVID-19 infection in Kidney Transplant Recipients Dr. Kamal Kant Kohli25 Oct 2022 6:00 PM ISTSPAIN: According to research published in Clinical Kidney Journal, the monoclonal antibody sotrovimab can be safely utilized in kidney transplant...
COVID-19 Treatment: GSK Sotrovimab, Roche antibody cocktail casirivimab-imdevimab no longer recommended by WHO Ruchika Sharma22 Sept 2022 4:14 PM ISTBoth therapies continue to be recommended for use by the European drugs regulator.
Sotrovimab effectively cuts progression of COVID-19 in nonhospitalized, high-risk patients: JAMA Dr. Shravani Dali9 April 2022 11:45 AM ISTSotrovimab can be used as an effective treatment option for non-hospitalized, high-risk patients with mild to moderate COVID-19, according to a...
GSK-Vir COVID therapy Sotrovimab authorization junked by USFDA Roshni Dhar8 April 2022 11:17 AM ISTThe U.S. health regulator said on Tuesday GlaxoSmithKline and Vir Biotechnology's antibody therapy was no longer authorized as a COVID-19 treatment,...
Health Bulletin 7/April/2022 Roshni Dhar7 April 2022 5:51 PM ISTHere are the top health stories for today: Health Ministry denies detection of XE variant in India In response to the media reports that...
USFDA junks authorization of GSK- Vir COVID therapy Sotrovimab Ruchika Sharma6 April 2022 4:20 PM ISTSotrovimab is no longer authorized to treat COVID-19 in any US region due to increases in the proportion of COVID-19 cases caused by the Omicron BA.2...
USFDA amends emergency use authorization for Sotrovimab due to Omicron BA.2 Subvariant Ruchika Sharma27 March 2022 10:15 AM ISTSan Francisco: GlaxoSmithKline plc and Vir Biotechnology, Inc. have announced that the US Food and Drug Administration (USFDA) has amended...
